Product Information
LORAZEPAM 2 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0695 per EA under NDC 00904600960. Its NADAC has been published 640 times since Nov 28, 2013.
FDA first approved this application on Jul 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904600960
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA078203FDA Approved
7/30/2007
TE Code
AB
On Market Since
10/9/2009
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG TABLET has been published 640 times since Nov 28, 2013, and over the history we have for it it has risen 45.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0695 per EA |
|---|---|
| All-time high | $0.0866 (Jan 10, 2024) |
| All-time low | $0.0399 (Jan 17, 2018) |
| 52-week high | $0.0764 |
| 52-week low | $0.0695 |
| Median price | $0.0626 |
| Average price | $0.0596 |
| Largest weekly change | -30.9% (Nov 20, 2024) |
| Weeks tracked | 640 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-9.0%
3Y
+4.1%
5Y
-9.4%
All
+45.0%
Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lorazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0695 per EA (NDC 00904600960), effective Feb 25, 2026.
How has the price of LORAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG TABLET has risen 45.0%. It has been tracked across 640 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG TABLET?
Since Nov 28, 2013, the NADAC for LORAZEPAM 2 MG TABLET has ranged from a low of $0.0399 (Jan 17, 2018) to a high of $0.0866 (Jan 10, 2024), with a median of $0.0626 per EA.
Are there cheaper alternatives to LORAZEPAM 2 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 2 MG TABLET, is $0.0424 per EA — about 39% below LORAZEPAM 2 MG TABLET.
Who manufactures LORAZEPAM 2 MG TABLET?
LORAZEPAM 2 MG TABLET (NDC 00904600960) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.